EGFR L858R/T790M inhibitors (Jubilant Lifesciences)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEGFR L858R/T790M inhibitors (Jubilant Lifesciences)
Drug Alias NameJIEM-0186JIEM-0235
ClassificationSmall molecules
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonistsAnticancer protein kinase inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJubilant Pharmova Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJubilant Pharmova Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A